Startseite An essential splice site mutation (c.317+1G>A) in the TSHR gene leads to severe thyroid dysgenesis
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

An essential splice site mutation (c.317+1G>A) in the TSHR gene leads to severe thyroid dysgenesis

  • Hakan Cangul EMAIL logo , Halil Saglam , Yaman Saglam , Erdal Eren , Durmus Dogan , Michaela Kendall , Omer Tarim , Eamonn R. Maher und Timothy G. Barrett
Veröffentlicht/Copyright: 23. Mai 2014

Abstract

Congenital hypothyroidism (CH) is the most common neonatal endocrine disorder and 2% of cases have familial origin. Our aim in this study was to determine the genetic alterations in two siblings with CH coming from a consanguineous family. Because CH is often inherited in autosomal recessive manner in consanguineous/multicase-families, we first performed genetic linkage studies to all known causative CH loci followed by conventional sequencing of the linked gene. The family showed potential linkage to the TSHR locus, and we detected an essential splice site mutation (c.317+1G>A) in both siblings. RT-PCR analysis confirmed the functionality of the mutation. The mutation was homozygous in the cases whereas heterozygous in carrier parents and an unaffected sibling. Here we conclude that thyroid agenesis in both siblings in this study originates from c.317+1G>A splice site mutation in the TSHR gene, and this study underlines the importance of detailed molecular genetic studies in the definitive diagnosis and classification of CH.


Corresponding author: Hakan Cangul, MD, Department of Medical Genetics, Bahcesehir University School of Medicine, Istanbul, Turkey, Phone: +90 216 4684239, Fax: +90 216 4684567, E-mail:

Acknowledgments

We are thankful to the family for their participation in this study.

Conflict of interest statement:

The authors declare no conflict of interest.

References

1. Medeiros-Neto G, Knobel M, DeGroot LJ. Genetic disorders of the thyroid hormone system. In: Baxter JD, editor. Genetics in endocrinology. Philadelphia, PA: Lippincott Williams & Wilkins, 2002:375–402.Suche in Google Scholar

2. Fisher DA. Second international conference on neonatal thyroid screening: progress report. J Pediatr 1983;102:653–4.10.1016/S0022-3476(83)80228-5Suche in Google Scholar

3. Park SM, Chatterjee VK. Genetics of congenital hypothyroidism. J Med Genet 2005;42:379–89.10.1136/jmg.2004.024158Suche in Google Scholar PubMed PubMed Central

4. Parmentier M, Libert F, Maenhaut C, Lefort, A, Gérard, C, et al. Molecular cloning of the thyrotropin receptor. Science 1989;246:1620–2.10.1126/science.2556796Suche in Google Scholar PubMed

5. Vassart G, Dumont JE. The thyrotropin receptor and regulation of thyrocyte function and growth. Endocr Rev 1992;13: 596–611.Suche in Google Scholar

6. Smits G, Campillo M, Govaerts C, Janssens V, Richter C, et al. Glycoprotein hormone receptors: determinants in leucine-rich repeats responsible for ligand specificity. EMBO J 2003;22:2692–703.10.1093/emboj/cdg260Suche in Google Scholar PubMed PubMed Central

7. Refetoff S. Resistance to thyrotropin. J Endocrinol Invest 2003;26:770–9.10.1007/BF03347364Suche in Google Scholar PubMed

8. Sunthornthepvarakul T, Gottschalk ME, Hayashi Y, Refetoff S. Resistance to thyrotropin caused by mutations in the thyrotropin-receptor gene. N Engl J Med 1995;332:155–60.10.1056/NEJM199501193320305Suche in Google Scholar PubMed

9. Beck-Peccoz P, Persani L, Calebiro D, Bonomi M, Mannavola D, et al. Syndromes of hormone resistance in the hypothalamic-pituitary-thyroid axis. Best Pract Res Clin Endocrinol Metab 2006;20:529–46.10.1016/j.beem.2006.11.001Suche in Google Scholar PubMed

10. Cangul H, Aycan Z, Saglam H, Forman JR, Cetinkaya S, et al. TSHR is the main causative-locus in autosomal recessively inherited thyroid dysgenesis. J Pediatr Endocrinol Metabol 2012;25:419–26.10.1515/jpem-2012-0053Suche in Google Scholar PubMed

11. Cangul H, Morgan NV, Forman JR, Saglam H, Aycan Z, et al. Novel TSHR mutations in consanguineous families with congenital non-goitrous hypothyroidism. Clin Endocrinol (Oxf) 2010;73:671–7.10.1111/j.1365-2265.2010.03849.xSuche in Google Scholar PubMed

12. Baş VN, Cangul H, Agladioglu SY, Kendall M, Cetinkaya S, et al. Mild and severe congenital primary hypothyroidism in two patients by thyrotropine receptor (TSHR) gene mutation. J Pediatr Endocrinol Metab 2012;25:1153–6.10.1515/jpem-2012-0211Suche in Google Scholar PubMed

13. Cangul H, Aycan Z, Olivera-Nappa A, Saglam H, Schoenmakers NA, et al. Thyroid dyshormonogenesis is mainly caused by TPO mutations in consanguineous community. Clin Endocrinol (Oxf) 2012;79:275–81.10.1111/cen.12127Suche in Google Scholar

14. Schoenmakers NA, Cangul H, Nicholas A, Schoenmakers E, Lyons, G, et al. A comprehensive next generation sequencing-based strategy for genetic diagnosis in congenital hypothyroidism. Endocr Abstr 2013;33:OC2.9, DOI:10.1530/endoabs.33.OC2.9.Suche in Google Scholar

15. Cangul H, Aycan Z, Kendall M, Baş VN, Saglam Y, et al. A truncating DUOX2 mutation (R434X) causes severe congenital hypothyroidism. J Pediatr Endocrinol Metab 2014;27:323–7.10.1515/jpem-2013-0314Suche in Google Scholar

16. Baş VN, Aycan Z, Cangul H, Kendall M, Ağladıoğlu SY, et al. A common thyroid peroxidase gene mutation (G319R) in Turkish patients with congenital hypothyroidism could be due to a founder effect. J Pediatr Endocrinol Metab 2014;27:383–7.10.1515/jpem-2013-0203Suche in Google Scholar

17. Cangul H, Boelaert K, Dogan M, Saglam Y, Kendall M, et al. Novel truncating thyroglobulin gene mutations associated with congenital hypothyroidism. Endocrine 2014;45:206–12.10.1007/s12020-013-0027-7Suche in Google Scholar

18. Cangul H, Saglam H, Aycan Z, Yakut T, Gulten T, et al. Locus heterogeneity and novel TSHR mutations in consanguineous families with congenital non-goitrous hypothyroidism. J Med Genet 2010;47(Suppl 1);S59.Suche in Google Scholar

19. Cangul H, Morgan NV, Pasha S, Kirby GA, Karkcukak M, et al. Genetic heterogeneity in congenital hypothyroidism. J Med Genet 2009;46(Suppl 1);S74.Suche in Google Scholar

20. Cangul H, Schoenmakers NA, Saglam H, Doganlar D, Saglam Y, et al. A deletion including exon 2 of the TSHR gene is associated with thyroid dysgenesis and severe congenital hypothyroidism. J Pediatr Endocrinol Metab 2014;27:731–5.10.1515/jpem-2014-0011Suche in Google Scholar

21. Van Vliet G. Treatment of congenital hypothyroidism. Lancet 2001;358:86–7.10.1016/S0140-6736(01)05376-4Suche in Google Scholar

22. Dubuis JM, Glorieux J, Richer F, Deal CL, Dussault JH, et al. Outcome of severe congenital hypothyroidism: closing the developmental gap with early high dose levothyroxine treatment. J Clin Endocrinol Metab 1996;81:222–7.Suche in Google Scholar

23. Castanet M, Polak M, Bonaiti-Pellie C, Lyonnet S, Czernichow P, et al. Nineteen years of national screening for congenital hypothyroidism: familial cases with thyroid dysgenesis suggest the involvement of genetic factors. J Clin Endocrinol Metab 2001;84:2502–6.10.1210/jcem.86.5.7501Suche in Google Scholar PubMed

24. Van Durme J, Horn F, Costagliola S, Vreind G, Vassart G, et al. GRIS: glycoprotein-hormone receptor information system. Mol. Endocrinol 2006;20:2247–55.Suche in Google Scholar

25. Abramowicz MJ, Duprez L, Parma J, Vassart G, Heinrichs, C. Familial congenital hypothyroidism due to inactivating mutation of the thyrotropin receptor causing profound hypoplasia of the thyroid gland. J Clin Invest 1997;99:3018–24.10.1172/JCI119497Suche in Google Scholar PubMed PubMed Central

26. Kleinau G, Krause G. Thyrotropin and homologous glycoprotein hormone receptors: structural and functional aspects of extracellular signalling mechanisms. Endocr Rev 2009;30:133–51.10.1210/er.2008-0044Suche in Google Scholar PubMed

27. Fan QR, Hendrickson WA. Structure of human follicle-stimulating hormone in complex with its receptor. Nature 2005;433:269–77.10.1038/nature03206Suche in Google Scholar PubMed PubMed Central

28. Sanders J, Chirgadze DY, Sanders P, Baker S, Sullivan A, et al. Crystal structure of the TSH receptor in complex with a thyroid-stimulating autoantibody. Thyroid 2007;17:395–410.10.1089/thy.2007.0034Suche in Google Scholar PubMed

29. Szkudlinski MW, Fremont V, Ronin C, Weintraub BD. Thyroid-stimulating hormone and thyroid-stimulating hormone receptor structure-function relationships. Physiol Rev 2002;82:473–502.10.1152/physrev.00031.2001Suche in Google Scholar PubMed

30. Vassart G, Pardo L, Costagliola S. A molecular dissection of the glycoprotein hormone receptors. Trends Biochem Sci 2004;29:119–26.10.1016/j.tibs.2004.01.006Suche in Google Scholar PubMed

31. Alberti L, Proverbio MC, Costagliola S, Romoli R, Boldrighini B, et al. Germline mutations of TSH receptor gene as cause of nonautoimmune subclinical hypothyroidism. J Clin Endocrinol Metab 2002;87:2549–55.10.1210/jcem.87.6.8536Suche in Google Scholar PubMed

32. Calebiro D, de Filippis T, Lucchi S, Covino C, Panigone S, et al. Intracellular entrapment of wild-type TSH receptor by oligomerization with mutants linked to dominant TSH resistance. Hum Mol Genet 2005;14:2991–3000.10.1093/hmg/ddi329Suche in Google Scholar PubMed

Received: 2014-1-29
Accepted: 2014-4-11
Published Online: 2014-5-23
Published in Print: 2014-9-20

©2014 by De Gruyter

Artikel in diesem Heft

  1. Frontmatter
  2. Review article
  3. Towards an optimization of the management of endocrine complications of thalassemia
  4. Original articles
  5. The natural course of Hashimoto’s thyroiditis in children and adolescents
  6. Muscle strength and body composition during the transition phase in patients treated with recombinant GH to final height
  7. Benign vaginal bleeding in 24 prepubertal patients: clinical, biochemical and imaging features
  8. Evaluation of epicardial adipose tissue, carotid intima-media thickness and ventricular functions in obese children and adolescents
  9. Counseling patients with succinate dehydrogenase subunit defects: genetics, preventive guidelines, and dealing with uncertainty
  10. Pubertal development profile in patients with Turner syndrome
  11. A novel CASR mutation associated with neonatal severe hyperparathyroidism transmitted as an autosomal recessive disorder
  12. Serum insulin-like growth factor-binding protein-3 level correlated with glycemic control and lipid profiles in children and adolescents with type 1 diabetes
  13. Adult human liver mesenchymal progenitor cells express phenylalanine hydroxylase
  14. Clinical applicability of rapid detection of SRY and DYS14 genes in patients with disorders of sex development using an indigenously developed 5′ exonuclease based assay
  15. Hereditary 1,25-dihydroxyvitamin D-resistant rickets with alopecia in four Egyptian families: report of three novel mutations in the vitamin D receptor gene
  16. Permanent neonatal diabetes mellitus in Jordan
  17. The effect of adenotonsilectomy on ghrelin, leptin, IGF-1 levels and growth parameters in children with adenotonsillar hypertrophy
  18. The role of anti-Mullerian and inhibin B hormones in the evaluation of 46,XY disorders of sex development
  19. The evaluation of thyroid carcinoma in childhood and concomitance of autoimmune thyroid disorders
  20. Lipid patterns in treated growth hormone deficient children vs. short stature controls
  21. Assessment of aortic morphology and compliance in children and adolescents with Ullrich-Turner syndrome (UTS) using magnetic resonance imaging (MRI)
  22. Management of central diabetes insipidus with oral desmopressin lyophilisate in infants
  23. Maternal factors and complications of preterm birth associated with neonatal thyroid stimulating hormone
  24. Patient reports
  25. A rare case of pituitary infarction leading to spontaneous tumour resolution and CSF-sella syndrome in an 11-year-old girl and a review of the paediatric literature
  26. Rare case of homozygous epimerase deficiency and heterozygous of duarte 2 variant
  27. Persistent congenital hyperinsulinism in two patients with Beckwith-Wiedemann syndrome due to mosaic uniparental disomy 11p
  28. Growth hormone treatment in a patient with Hurler-Scheie syndrome
  29. Neonatal diagnosis of a patient with hypoparathyroidism, sensorineural deafness and renal dysplasia (HDR) syndrome associated with cerebral infarction
  30. Early-onset diabetes mellitus and neurodevelopmental retardation: the first Greek case of Wolcott-Rallison syndrome
  31. Type III Bartter-like syndrome in an infant boy with Gitelman syndrome and autosomal dominant familial neurohypophyseal diabetes insipidus
  32. Cushing’s syndrome: hidden risk in usage of topical corticosteroids
  33. Prader-Willi syndrome: a case report with atypical developmental features
  34. Berardinelli-Seip congenital lipodystrophy: an autosomal recessive disorder with rare association of duodenocolonic polyps
  35. Ectopic Cushing syndrome secondary to metastatic medullary thyroid cancer in a child with multiple endocrine neoplasia syndrome type 2B: clues to early diagnosis of the paraneoplastic syndromes
  36. Ovarian hyperstimulation syndrome treated by medroxyprogesterone acetate
  37. Symptomatic cerebral infarction in a child with severe diabetic ketoacidosis
  38. A rare case of familial Cushing’s syndrome with a common presentation of weight gain due to a mutation of the PRKAR1A gene causing isolated primary pigmented nodular adrenocortical disease
  39. Multiple autoimmunity, type 1 diabetes (T1DM), autoimmune thyroiditis and thyroid cancer: is there an association? A case report and literature review
  40. Cholestasis and protein-losing enteropathy secondary to hyperthyroidism in a 6-year-old girl
  41. Short communication
  42. An essential splice site mutation (c.317+1G>A) in the TSHR gene leads to severe thyroid dysgenesis
  43. Letter to the Editor
  44. Pubertal gynecomastia: what about the remaining 10%?
Heruntergeladen am 27.9.2025 von https://www.degruyterbrill.com/document/doi/10.1515/jpem-2014-0048/html
Button zum nach oben scrollen